Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NovoCure Ltd.
Dana-Farber Cancer Institute
Massachusetts General Hospital
Servier
Emory University
Memorial Sloan Kettering Cancer Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Neonc Technologies, Inc.
Essen Biotech
Roswell Park Cancer Institute
University of Florida
University of Cincinnati
Mayo Clinic
Massachusetts General Hospital
Centre Hospitalier Universitaire de Besancon
Mayo Clinic
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
University of Florida